PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease models. Albornoz EA, Mardon K, Bhalla R, Kumar V, et al. Brain 2025 Oct 16:awaf372. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Albornoz EA, Mardon K, Bhalla R, Kumar V, et al. PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease models. Brain 2025 Oct 16:awaf372. doi: 10.1093.
PMID: 41099134